Quarterly report pursuant to Section 13 or 15(d)

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.24.2.u1
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2022 $ 11,628 $ 45,944,478 $ (38,641,085) $ 7,315,021
Balance at beginning, Common shares (in shares) at Dec. 31, 2022 11,627,609      
Share-Based Compensation   733,472   733,472
Share-Based Payments to Vendors $ 44 165,859   165,903
Share-Based Payments to Vendors (in shares) 44,186      
Net Income (Loss)     (2,902,957) (2,902,957)
Balance at ending at Mar. 31, 2023 $ 11,672 46,843,809 (41,544,042) 5,311,439
Balance at ending, Common shares (in shares) at Mar. 31, 2023 11,671,795      
Balance at beginning at Dec. 31, 2022 $ 11,628 45,944,478 (38,641,085) 7,315,021
Balance at beginning, Common shares (in shares) at Dec. 31, 2022 11,627,609      
Net Income (Loss)       (6,348,197)
Balance at ending at Jun. 30, 2023 $ 13,005 51,192,646 (44,989,282) 6,216,369
Balance at ending, Common shares (in shares) at Jun. 30, 2023 13,005,128      
Balance at beginning at Mar. 31, 2023 $ 11,672 46,843,809 (41,544,042) 5,311,439
Balance at beginning, Common shares (in shares) at Mar. 31, 2023 11,671,795      
Share-Based Compensation   806,485   806,485
Issuance of shares of common stock $ 602 3,543,010   3,543,612
Issuance of shares of common stock (in shares) 601,851      
Pre-funded Warrant Exercise $ 731 (658)   73
Pre-funded Warrant Exercise (in shares) 731,482      
Net Income (Loss)     (3,445,240) (3,445,240)
Balance at ending at Jun. 30, 2023 $ 13,005 51,192,646 (44,989,282) 6,216,369
Balance at ending, Common shares (in shares) at Jun. 30, 2023 13,005,128      
Balance at beginning at Dec. 31, 2023 $ 14,468 57,871,070 (53,218,853) $ 4,666,685
Balance at beginning, Common shares (in shares) at Dec. 31, 2023 14,468,229     14,468,229
Share-Based Compensation   894,523   $ 894,523
Share-Based Payments to Vendors $ 90 305,510   305,600
Share-Based Payments to Vendors (in shares) 90,000      
Issuance of shares of common stock $ 1,140 4,298,334   4,299,474
Issuance of shares of common stock (in shares) 1,139,662      
Warrant Exercise $ 59 210,140   210,199
Warrant Exercise (in shares) 59,211      
Net Income (Loss)     (4,377,889) (4,377,889)
Balance at ending at Mar. 31, 2024 $ 15,757 63,579,577 (57,596,742) 5,998,592
Balance at ending, Common shares (in shares) at Mar. 31, 2024 15,757,102      
Balance at beginning at Dec. 31, 2023 $ 14,468 57,871,070 (53,218,853) $ 4,666,685
Balance at beginning, Common shares (in shares) at Dec. 31, 2023 14,468,229     14,468,229
Net Income (Loss)       $ (8,499,715)
Balance at ending at Jun. 30, 2024 $ 15,996 65,130,047 (61,718,568) $ 3,427,475
Balance at ending, Common shares (in shares) at Jun. 30, 2024 15,996,168     15,996,168
Balance at beginning at Mar. 31, 2024 $ 15,757 63,579,577 (57,596,742) $ 5,998,592
Balance at beginning, Common shares (in shares) at Mar. 31, 2024 15,757,102      
Share-Based Compensation   1,016,998   1,016,998
Share-Based Payments to Vendors $ 106 213,394   213,500
Share-Based Payments to Vendors (in shares) 106,000      
Issuance of shares of common stock $ 133 320,078   320,211
Issuance of shares of common stock (in shares) 133,066      
Net Income (Loss)     (4,121,826) (4,121,826)
Balance at ending at Jun. 30, 2024 $ 15,996 $ 65,130,047 $ (61,718,568) $ 3,427,475
Balance at ending, Common shares (in shares) at Jun. 30, 2024 15,996,168     15,996,168